Language: 简体中文 English
Your location: Home > Program
Query:
Date:
  • All
  • November 19, 2026
  • November 20, 2026
  • November 21, 2026
Hall:
  • All
  • 5th‑Floor Grand Ballroom
  • S101
  • S102
  • S103
  • S105
  • S106
  • S107
  • S109
  • S110
  • S111
  • S201
  • S202
  • S203
  • S204
  • S205
  • S206
  • S207
  • V11
  • V22
  • V23
  • V24
  • V25
  • InterContinental Ballroom 1
Subject:
  • All
  • Plenary Session
  • Oncology
  • Minimally Invasive Surgery
  • Stones
  • Incontinence
  • Robotic Surgery
  • Clinical Research
  • Basic and Translational Science
  • Female Urology
  • Andrology
  • Nursing
  • Infection
  • Renal Transplantation
  • Laser Surgery
  • Community Urology
  • Reconstructive Surgery
  • Adrenals
  • Pediatric Urology
  • Smart Surgery
  • Urological Engineering
  • Special Session
  • Prostate Cancer Pathfinders: Evidence into Action
  • Prostate Neoplasms Session
  • Benign Diseases Diagnosis & Treatment Session
  • Urolithiasis Standardized Care Project
  • Discovering Urological Frontiers
  • Urology & Prostate
  • Rising Leaders Urology
  • Urologic Oncology Session
  • Training Program for Urological Department
  • Precision Care in Urologic Oncology
  • Uro-Oncology Leadership & Innovation Forum
  • Remote Session: Normalized Surgical Practice
  • RCC Immunotherapy Session
  • Intelligent Leadership in Prostate Care
  • Bladder Cancer Session
  • MP + SP in URO Seminar
  • Benign Prostatic Hyperplasia Session
  • Ingenuity Exploration
  • Renal Cell Carcinoma Session
  • Prostate Cancer Session

November 21, 2026

S203

November 21, 2026 08:00-08:10 Opening Remarks Clinical Research
Moderator :
1 08:00-08:05

Opening Remarks

Shaogang Wang China
2 08:05-08:10

Opening Remarks

Xu Zhang China
November 21, 2026 08:10-09:55 Session 1: Themed Lecture 1 Clinical Research
1 08:10-08:25

Enfortumab Vedotin + Pembrolizumab in Previously Untreated Locally Advanced or Metastatic Urothelial Cancer: Exploratory Analyses Based on Disease-Related Characteristics from EV-302

Shaogang Wang China
2 08:25-08:40

Capivasertib (capi) + abiraterone (abi) vs placebo (pbo) + abi in patients (pts) with PTEN-deficient de novo metastatic hormone-sensitive prostate cancer (mHSPC): Phase III CAPItello-281 Chinese subgroup analysis

Dingwei Ye China
3 08:40-08:55

Phase I clinical study of LACO-Stim modified targeted CD70 CAR-T cells in the treatment of metastatic renal clear cell carcinoma

Linhui Wang China
4 08:55-09:10

Early precision prevention and control of lung cancer

Wenhua Liang China
5 09:10-09:25

Prospective, single-arm Phase II study of disitamab vedotin in locally advanced or metastatic extramammary Paget's disease with high HER2 expression (Formula-10)

Kai Yao China
6 09:25-09:40

Radioligand Therapy Clinical Trials: An Investigator and Drug Development Perspective

Scott T. Tagawa American Samoa
7 09:40-09:55

Discussion

Xiaofu Wang China
Pengchao Li China
Wenguang Wang China
Jun Li China
Wei Wang China
Kefeng Wang China
November 21, 2026 09:55-11:40 Session 2: Themed Lecture 2 Clinical Research
1 09:55-10:10

Efficacy of debulking radical prostatectomy for patients with high tumor burden metastatic prostate cancer achieving deep PSA remission after systemic treatment: a prospective multicenter cohort study

Liqun Zhou China
2 10:10-10:25

Clinical exploration of posterior approach radical prostatectomy

Xiaoming Cao China
3 10:25-10:40

Efficacy and Safety Evaluation of FANS f-URS Versus PCNL in the Treatment of 3-4cm Renal Stones - Preliminary Results of a Multi-Center Study

Wenqi Wu China
4 10:40-10:55

Study on the diagnostic efficacy of molecular imaging targeting CAⅨ in renal clear cell carcinoma

Liangyou Gu China
5 10:55-11:10

Intravesical Disitamab Vedotin (RC48) for BCG-Unresponsive High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicenter Phase I Trial

Xu Chen China
6 11:10-11:25

Emerging therapies in NMIBC: from clinical trials to future practice

Leslie Claire Licari Italy
7 11:25-11:40

Discussion

Hong Ma China
Jia Guo China
Fan Zhang China
Weidong Xu China
Shuaijun Ma China
Haowei He China
November 21, 2026 11:40-12:30 Session 3: Clinical Research Insider Clinical Research
Moderator :
1 11:40-12:30

Roundtable Discussion

Jiahua Pan China
Shusuan Jiang China
Yao Zhu China
Siming Li China
Qi Tang China
Shun Zhang China
Yige Bao China
November 21, 2026 12:30-13:30 Thematic Meeting Clinical Research
November 21, 2026 13:30-14:30 Session 4: Precision treatment frontiers Clinical Research
1 13:30-13:36

Genomic and Epigenomic Approaches to Target Discovery and Therapeutic Development

Jindan Yu United States
2 13:36-13:42

Multimodal Fusion Ultrasound for Precision Navigation

Karl Marvin Tan Philippines
3 13:42-13:48

Prospective Phase II Study of Neoadjuvant Targeted Immunotherapy Combined with Response-Adaptive Nephron-Sparing Strategy for High-Risk Upper Urinary Tract Urothelial Carcinoma

Jiwei Huang China
4 13:48-13:54

Ultrasound-guided balloon occlusion for hybrid partial nephrectomy: a non-randomized controlled trial

Heng Li China
5 13:54-14:00

Precision antegrade robotic inguinal lymph node dissection under fluorescence imaging combined with color Doppler ultrasound localization

Minghua Ren China
6 14:00-14:06

Artificial intelligence based augmented reality navigation in minimally invasive partial nephrectomy

Xiaolei Shi China
7 14:06-14:12

Diagnostic efficacy and safety of PSMA-targeted near-infrared fluorescent contrast agent DGPR1008 in robotic-assisted radical prostatectomy: a single-center phase II clinical trial

Yuchi Wang China
8 14:12-14:18

Clinical research on bladder preservation with MIBC patients

Xiongbing Zu China
9 14:18-14:30

Discussion

Qizhao Zhou China
Zhaowei Zhu China
Yongde Xu China
xiaoshuang tang China
Xiaolong Jia China
Youcheng Lin China
November 21, 2026 14:30-15:30 Session 5: Precision diagnosis frontiers Clinical Research
1 14:30-14:36

Prospective, multicenter study on the non-invasive diagnosis of urothelial carcinoma through urine SIX6 methylation detection

Chuanliang Xu China
2 14:36-14:42

Deficiencies in the diagnostic system for prostate cancer - A series of explorations to enhance the diagnostic accuracy of prostate cancer

Jun Xiao China
3 14:42-14:48

Integrated diagnostic study of urine metabolomics combined with MRI radiomics in patients with prostate cancer

Wangli Mei China
4 14:42-14:54

Urinary detection based on methylation for the diagnosis and recurrence monitoring of urothelial carcinoma: a multicenter, prospective clinical study

Yucai Wu China
5 14:54-15:00

Application of dual-modal liquid biopsy based on CRISPR/Cas12a in precision diagnosis of prostate cancer

Xingyu Zhong China
6 15:00-15:06

Multi-center research, development, and validation of UPGRADE-Dx: A non-invasive prostate cancer precision screening and biopsy guidance model based on low-abundance proteomics in urine

Yubo Wang China
7 15:06-15:12

Combined application of GPR143, SV2B, and NMRK2 immunohistochemical markers effectively distinguishes TFE3-rearranged renal cell carcinoma from renal clear cell carcinoma and papillary renal cell carcinoma: a multicenter study

Huayi Feng China
8 15:12-15:18

Research on the application value of MRI artificial intelligence in precise biopsy diagnosis of prostate cancer: a prospective diagnostic trial

Ruiyi Deng China
9 15:18-15:30

Discussion

Jie Dong China
Gan Yu China
Boxing Su China
Xiangdong Li China
Tao Wang China
Zhuoyuan Lin China
November 21, 2026 15:30-16:30 Session 6: Multi-center prospective study Clinical Research
1 15:30-15:36

Study on the necessity of pelvic lymph node dissection in radical cystectomy for high-risk non-muscle-invasive bladder cancer - a prospective multicenter study

Qiang Lv China
2 15:36-15:42

Darolutamide combined with ADT versus Bicalutamide combined with ADT as adjuvant therapy after radical surgery for high-risk localized prostate cancer: Interim analysis

Zijin Wan China
3 15:42-15:48

Efficacy and safety of a domestic water vapor thermal therapy system in patients with benign prostatic hyperplasia: a prospective, multicenter, single-blind, randomized controlled trial

Yujie Dong China
4 15:48-15:54

The effect of a treatment method based on lipus innovative technology on the recovery of urinary incontinence after radical androgen deprivation therapy (RARP): a randomized, double-blind, prospective, multicenter clinical trial

Anze Yu China
5 15:54-16:00

A multi-center randomized controlled study on percutaneous nephrolithotomy guided by CT-ultrasound fusion and conventional ultrasound

Bojun Li China
6 16:00-16:06

Safety study of autologous dendritic cell vaccine Prolevis in metastatic castration-resistant prostate cancer patients who have failed standard treatment: a multicenter, non-randomized, open-label, dose-escalation Phase I clinical trial

Yifan Chang China
7 16:06-16:12

Evaluation of early efficacy of domestic prostate suspension system in the treatment of benign prostatic hyperplasia: a multicenter prospective randomized parallel controlled study

Qifeng Cao China
8 16:12-16:18

A prospective, multicenter, randomized controlled clinical trial on the prevention of GnRH agonist-induced flare-up effects with rivarubicin

Chunguang Yang China
9 16:18-16:30

Discussion

Wei Li China
Songliang Du China
Zijie Wang China
E Lin China
Huidong Fang China
Lujia Zou China
November 21, 2026 16:30-17:30 Session 7: Single-center prospective study Clinical Research
1 16:30-16:36

Application of Prostate-Specific Membrane Antigen (PSMA) PET/MRI-Guided Targeted Prostate Biopsy in Patients with PI-RADS Score ≤3 and Previous Negative Biopsy: A Single-Center, Prospective, Open-Label, Randomized Controlled Study

Yuxuan Zhao China
2 16:36-16:42

Tislelizumab Combined with Radiotherapy for Bladder Preservation in High-Risk Non-Muscle-Invasive Bladder Cancer Following BCG Failure: A Single-Arm, Phase 2 Clinical Trial

Zhiyong Li China
3 16:42-16:48

resection followed by sequential endocrine therapy for high tumor burden metastatic prostate cancer: a single-center prospective non-randomized controlled study

Qiang Fu China
4 16:48-16:54

Phase II clinical study of CD70 immuno-PET imaging for the diagnosis of renal clear cell carcinoma

Weijun Wei China
5 16:54-17:00

Prospective randomized clinical study on the selection of bladder instillation chemotherapy drugs guided by patient-derived tumor-like cell clusters after surgery for non-muscle-invasive bladder cancer

Wei Zhang China
6 17:00-17:06

Phase Ia clinical trial of intravesical instillation of recombinant oncolytic adenovirus KD01 for the treatment of high-risk non-muscle-invasive bladder cancer: a single-center, open-label, non-randomized study

Lilong Liu China
7 17:06-17:12

Detection characteristics of prostatic intraductal carcinoma and its association with biochemical recurrence after radical prostatectomy: a single-center retrospective study based on 7060 specimens

Zhaodelong Dai China
8 17:12-17:18

The application value of targeted biopsy based on real-time radioactive measurement with 123I-PSMA-7 in the diagnosis of clinically significant prostate cancer: a single-center prospective exploratory study

Qiming Yang China
9 17:18-17:30

Discussion

Dechao Feng China
Wenlong Zhong China
Xinyuan Li China
Qingyang Liu China
Yuanyuan Yang China
Jinzhou Xu China
November 21, 2026 17:30-18:36 Session 8: Retrospective study Clinical Research
1 17:30-17:36

Research on Prostate Biopsy Decision-making Model Based on Morning Urine PCA3 and mpMRI Features

Shaoxi Niu China
2 17:36-17:42

Single-center, retrospective cohort analysis of pelvic lipomatosis - Renji experience

Yuchen Wu China
3 17:42-17:48

The current application status and pathological benefits of lymph node dissection in radical prostatectomy: a retrospective study based on 1861 cases from a single center

Dingkai Zhu China
4 17:48-17:54

High-frequency mutations and genotype-phenotype analysis of the VHL gene: a retrospective study based on 820 Chinese patients with von Hippel-Lindau syndrome

Chuandong Wang China
5 17:54-18:00

A 12-year multicenter review of laparoscopic or robotic-assisted laparoscopic endovascular stenting for the treatment of type 1 nutcracker syndrome

Fangmin Chen China
6 18:00-18:06

Clinical Research on the Treatment of Ureteral Polyp with Lingual Mucosa Ureteroplasty

Shuaishuai Chai China
7 18:06-18:12

Analysis of clinical epidemiological characteristics and regional heterogeneity of prostate cancer in Jiangsu Province: based on a survey of 3,717 patients from 17 centers

Lixin Hua China
8 18:12-18:18

The prognostic significance of pathological nerve invasion in prostate cancer: when coexistent with positive resection margins, it significantly promotes castration-resistant transformation, a multi-center ten-year follow-up study

Xin Chen China
9 18:18-18:24

Preliminary clinical observation on the safety and efficacy of Rezūm® thermal vapor ablation therapy in patients with benign prostatic hyperplasia and comorbid high-risk cardiovascular diseases: a single-arm, single-center retrospective study

Yibo Tang China
10 18:24-18:36

Discussion

Erxiati Mi China
Dingwei Xue China
Junlin Lu China
Gongwei Long China
Jianxuan Sun China
Qidong Xia China
November 21, 2026 18:36-18:40 Summary Clinical Research
1 18:36-18:40

Summary

Shaogang Wang China